Pinnacle Associates LTD Coll Plant Biotechnologies LTD Transaction History
Pinnacle Associates LTD
- $6.3 Billion
- Q3 2024
A detailed history of Pinnacle Associates LTD transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Pinnacle Associates LTD holds 468,109 shares of CLGN stock, worth $1.74 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
468,109
Previous 564,360
17.05%
Holding current value
$1.74 Million
Previous $2.8 Million
17.05%
% of portfolio
0.04%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding CLGN
# of Institutions
17Shares Held
1.95MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC485KShares$1.8 Million0.21% of portfolio
-
Investment Management Of Virginia LLC464KShares$1.72 Million0.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$1.03 Million2.69% of portfolio
-
Brown Advisory Inc119KShares$443,2150.0% of portfolio
-
Amh Equity LTD75.6KShares$280,6500.52% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $41.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...